1 Product identity
Ingredient risk
No flagged ingredients
CoQHeart
BrandShaklee→Non-Nutrient/Non-Botanical Capsule 7 ingredients DSLD #5033Net contents: 30 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-01-25
2 Ingredients (7)
IngredientGroupSafety
Soybean OilSoybean Oil—
GLYCERYL PALMITOSTEARATEGlyceryl palmitostearate—
POLYGLYCERYL DIOLEATEPolyglycerols—
IN A GELATIN CAPSULEcapsule—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Coenzyme Q10 — Limited Evidence
⚠ May reduce warfarin efficacy
⚠ Mild GI effects
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Resveratrol — Conditionally Safe
⚠ Estrogenic activity
⚠ CYP enzyme inhibition
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID5033
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-01-25
6 More from Shaklee
View Shaklee Safety Scorecard → 32 products
+Fiber Shaklee Fiber Plan Powder Unflavored+Heart Cholesterol Reduction ComplexChewable Cal Mag PlusChewable Vita-C100 mgCholesterol Reduction ComplexCholesterol Regulation Complex7 Cite this page
Vancouver
Pkhakadze G. CoQHeart — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 17]. Available from: https://supplement.ge/products/dsld-5033/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG